Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Diagnostics
Fuzionaire advances radiolabeling chemistry
by Michael McCoy
October 12, 2019
| A version of this story appeared in
Volume 97, Issue 40
Fuzionaire Diagnostics has formed a joint venture with Japan Medical Isotope Technology Development to commercialize its fluorine-18 radiolabeling technology in Japan. Fuzionaire was founded last year on the basis of alkali metal catalysis discoveries made by Anton Toutov while working in the laboratory of chemistry Nobel laureate Robert Grubbs. The California-based company says the first application of the technique is producing 18F-labeled compounds for PET scans quickly and easily.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter